CN Patent

CN106687118A — 前药化合物及其用途

Assigned to Ligand Pharmaceuticals Inc · Expires 2017-05-17 · 9y expired

What this patent protects

本文提供了环状含磷前药化合物、它们的制备和它们的用途，诸如通过调节肝中的分子靶标来治疗疾病。

USPTO Abstract

本文提供了环状含磷前药化合物、它们的制备和它们的用途，诸如通过调节肝中的分子靶标来治疗疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN106687118A
Jurisdiction
CN
Classification
—
Expires
2017-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Ligand Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.